Given advances in antiretroviral therapy, the mortality rate for HIV infection has dropped
considerably over recent decades. However, people living with HIV (PLWH) experience …

Background: The use of integrase inhibitor-based antiretroviral therapy could be associated
with worse weight and metabolic outcomes in patients with HIV infection. Methods: PubMed …

Objective To compare the incidence of hypertension in people living with HIV receiving
integrase strand transfer inhibitor (INSTI)‐based antiretroviral therapy (ART) versus non …

Background Integrase strand-transfer inhibitors (INSTIs) and tenofovir alafenamide have
been associated with weight gain in several clinical trials and observational cohorts …

Background Although associations between older antiretroviral drug classes and
cardiovascular disease in people living with HIV are well described, there is a paucity of …

BACKGROUND: This study aimed to determine the correlation between human-
immunodeficiency-virus (HIV) infection and stroke, as well as to estimate the global …

Infections with human immunodeficiency virus (HIV) and acquired immune deficiency
syndrome (AIDS) represent one of the greatest health burdens worldwide. The complex …

The intersection of Human Immunodeficiency Virus (HIV) infection and cardiovascular
disease (CVD) represents a significant area of concern; advancements in antiretroviral …

Introduction The effect of long-term exposure to antiretroviral therapy (ART) on hypertension
in sub-Saharan Africa remains unclear. We aimed to determine the prevalence and …

While human immunodeficiency virus (HIV)-associated wasting has declined with significant
advances in antiretroviral therapy (ART), weight gain and metabolic syndrome (MetS) are …